Recent advances in molecular diagnosis for patients with cancer and haematological diseases by Dr Anna Schuh
WebEx Presentation on Wednesday 9th April 2014
We were delighted to be joined by Dr Anna Schuh, Consultant Haematologist at Oxford University Hospitals on 9th April 2014 for a special Webex event. Dr Anna Schuh, gave a most interesting presentation on recent advances in molecular diagnosis for patients with cancer and haematological diseases entitled ‘ Implementation of Personalized Medicine in Healthcare‘.
If you missed the event there is an opportunity to view the presentation and listen to the recording:-
This Webex was supported by Pfizer Ltd under a medical education goods and services contract.
A flyer produced for the event is available to download:- Flyer – Dr Anna Schuh – 9th April 2014
  |
Dr Anna Schuh, MD, PhD, MRCP, FRCPath is a consultant haematologist at Oxford University Hospitals. Her main research interests are with chronic lymphocytic leukaemia (CLL) and molecular diagnostics. She is a principle/chief investigator on a number of early and late Phase clinical trials in CLL. As the Head of the MDC, she leads on a translational research programme for the development, validation, standardisation and evaluation of clinical utility of NGS technologies. Her particular focus is with improving response prediction in CLL and other malignancies using whole genome sequencing.
|
